Osteoporosis Treatment Market – Growth, Future Prospects, and Competitive Analysis, 2017 – 2025, the global osteoporosis treatment market was valued at US$ 11,734.8 Mn in 2016, and is expected to reach US$ 16,512.7 Mn by 2025, expanding at a CAGR of 3.9% from 2017 to 2025
Browse Full Report Here: http://www.acutemarketreports.com/report/osteoporosis-treatment-market
Osteoporosis is a bone disease causing loss of bone density that occurs with age. It leads to million broken bones each year, and thus major reason of fractures, spinal problems, back pain, and loss of independence. According to the International Osteoporosis Foundation, around 200 million people suffer from this disease. Around 30% of all postmenopausal women suffer from osteoporosis in U.S. and Europe. It is observed that osteoporosis is one of the most neglected diseases despite the grave consequence it can cause to female health. Thus rising prevalence of osteoporosis is a serious public health concern. Programs to increase awareness of osteoporosis are conducted out by international and national bodies. Thus ageing population, rise in prevalence of osteoporosis, awareness programs are the key factors driving the osteoporosis treatment market.
The global osteoporosis treatment market is segmented by drug type into bisphosphonates, parathyroid hormone therapy, calcitonin, selective estrogen inhibitors modulator (SERM) and rank ligand inhibitors. Bisphosphonates is extensively used for prevention and treatment of osteoporosis, thus dominating the osteoporosis treatment market.
Browse the complete report at: http://www.acutemarketreports.com/report/osteoporosis-treatment-market
As of the current market scenario, North America dominated the global osteoporosis treatment market followed by the Europe. Around 75 million people are affected by osteoporosis in Europe, U.S. and Japan. Increasing prevalence of osteoporosis and aging population, and growing awareness about osteoporosis are the key factor driving the growth of osteoporosis treatment market. Asia Pacific is the fastest growing regional market for osteoporosis treatment. In emerging economies such as China, India there is rising awareness about prevalence of osteoporosis and enhancement in healthcare infrastructure, improving diagnostic and treatment that would boost the demand of osteoporosis treatment market.
Market Competition Assessment:
Key players in the global osteoporosis treatment market are Allergan Plc., Amgen, Inc., Actavis Plc., Eli Lilly and Company, F.Hoffmann La Roche Ltd, GlaxoSmithKline Pharmaceutical Ltd, Merck & Co AG, Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Teva Pharmaceuticals Industries Ltd. and others.
Download Free Request Sample: http://www.acutemarketreports.com/request-free-sample/109090
Key Market Movements:
– Ageing of populations worldwide is major reason for rise in the incidence of osteoporosis. Osteoporosis affects an estimated 75 million people in Europe, U.S. and Japan.
– Osteoporosis is a grave problem for all postmenopausal women health affecting almost 30% of postmenopausal women in U.S. and Europe.
– Worldwide, osteoporosis causes more than 8.9 million fractures annually, resulting in an osteoporotic fracture every 3 seconds.
– Entry of generics especially in emerging economies creates a lucrative opportunity for osteoporosis treatment market. Tymlos is approved by the U.S. FDA to treat osteoporosis in postmenopausal women at high risk of fracture, that would further propel the demand for osteoporosis treatments.
Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase II-Expert Panel Review
1.2.5. Approach Adopted
Chapter 2. Executive Summary
2.1. Global Osteoporosis Treatment Market Portraiture
2.1.1. Global Osteoporosis Treatment Market, by Drug Type, 2016
2.1.2. Global Osteoporosis Treatment Market, by Geography, 2016
Chapter 3. Osteoporosis Treatment: Market Dynamics and Future Outlook
3.1. Market Overview
3.4.1. Attractive Investment Proposition, by Geography
3.5. Competitive Landscape
3.5.1. Competitive Landscape, by Key Players, 2016
Chapter 4. Global Osteoporosis Treatment Market, by Drug Type, 2015 – 2025 (US$ Mn)
4.2. Attractive Investment Proposition: Global Osteoporosis Treatment Market, by Drug Type
4.4. Parathyroid Hormone Therapy
4.6. Selective Estrogen Inhibitors Modulator (SERM)
4.7. Rank Ligand Inhibitors
About – Acute Market Reports:
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements. We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.
Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online.